Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Flavoprotein enzymes are a broad superfamily of proteins characterized by the presence of a flavin nucleotide cofactor (FMN or FAD) derived from vitamin B2 (riboflavin)[5][2]. These enzymes are mostly oxidoreductases and catalyze redox reactions vital to primary energy metabolism, biosynthesis of essential cellular components, detoxification, DNA repair, and many other crucial biological functions[1][3]. Over 90 flavoprotein genes are encoded in the human genome, and defects in their biosynthesis, mutation, or cofactor deficiency are linked to diseases including cancer, cardiovascular, and neurological disorders[3][2][1]. Due to the diversity of this group, "Flavoprotein enzyme" is not a specific molecular target, but rather denotes a functional class containing many individual therapeutic targets such as xanthine oxidase, monoamine oxidase, and others.
Inhibition or enhancement of specific flavoprotein enzymatic activity (e.g., xanthine oxidase inhibition by allopurinol)\n- Supplementation of cofactors (riboflavin)\n- Modulation of associated metabolic pathways
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Flavoprotein enzyme.